STUDY OBJECTIVE: To estimate the annual period prevalence of co-occurring psychiatric illness and substance misuse among patients in primary care. DESIGN: Analysis of the general practice research database. SETTING: England and Wales, 1993-1998. PARTICIPANTS: Registered patients at 230 general practices representing 3.1% of the population. A comorbid case was defined as one with both a psychiatric diagnosis and substance misuse diagnosis (not including alcohol or tobacco) within a calendar year. A potentially chronic comorbid case was one that met this definition and, in addition, was treated in subsequent years for either a psychiatric condition or substance misuse. MAIN RESULTS: The annual period prevalence of comorbidity increased from 50/100 000 patient years of exposure (PYE) to 80/100 000 PYE, an increase of 62% during the study period. Rates of comorbid psychoses, comorbid schizophrenia, and comorbid paranoia increased by 147%, 128%, and 144%. The average age of comorbid cases decreased from 38 years to 34 years. Over 80% of comorbid cases were newly diagnosed in each study year, although many are treated in subsequent years for either psychiatric illness or substance misuse. CONCLUSIONS: This study provides data on the nature and extent of comorbidity in primary care in England and Wales. As the comorbidity rate is increasing by about 10% each year, and as comorbid cases are becoming younger, it is probable that the comorbidity rate will have increased beyond the study end point.
STUDY OBJECTIVE: To estimate the annual period prevalence of co-occurring psychiatric illness and substance misuse among patients in primary care. DESIGN: Analysis of the general practice research database. SETTING: England and Wales, 1993-1998. PARTICIPANTS: Registered patients at 230 general practices representing 3.1% of the population. A comorbid case was defined as one with both a psychiatric diagnosis and substance misuse diagnosis (not including alcohol or tobacco) within a calendar year. A potentially chronic comorbid case was one that met this definition and, in addition, was treated in subsequent years for either a psychiatric condition or substance misuse. MAIN RESULTS: The annual period prevalence of comorbidity increased from 50/100 000 patient years of exposure (PYE) to 80/100 000 PYE, an increase of 62% during the study period. Rates of comorbid psychoses, comorbid schizophrenia, and comorbid paranoia increased by 147%, 128%, and 144%. The average age of comorbid cases decreased from 38 years to 34 years. Over 80% of comorbid cases were newly diagnosed in each study year, although many are treated in subsequent years for either psychiatric illness or substance misuse. CONCLUSIONS: This study provides data on the nature and extent of comorbidity in primary care in England and Wales. As the comorbidity rate is increasing by about 10% each year, and as comorbid cases are becoming younger, it is probable that the comorbidity rate will have increased beyond the study end point.
Authors: M Farrell; S Howes; C Taylor; G Lewis; R Jenkins; P Bebbington; M Jarvis; T Brugha; B Gill; H Meltzer Journal: Addict Behav Date: 1998 Nov-Dec Impact factor: 3.913
Authors: Julia Granerod; Nicholas W S Davies; Parashar P Ramanuj; Ava Easton; David W G Brown; Sara L Thomas Journal: J Neurol Date: 2016-10-20 Impact factor: 4.849
Authors: Martin Frisher; Ilana Crome; John Macleod; David Millson; Peter Croft Journal: J Epidemiol Community Health Date: 2005-10 Impact factor: 3.710
Authors: Maju Mathew Koola; Robert P McMahon; Heidi J Wehring; Fang Liu; Kristen M Mackowick; Kimberly R Warren; Stephanie Feldman; Joo-Cheol Shim; Raymond C Love; Deanna L Kelly Journal: J Psychiatr Res Date: 2012-05-16 Impact factor: 4.791
Authors: Sophie Wood; Amanda Marchant; Mark Allsopp; Kathleen Wilkinson; Jackie Bethel; Hywel Jones; Ann John Journal: BMJ Open Date: 2019-08-04 Impact factor: 2.692